Difference between revisions of "Template:Histamine receptor modulators"
Jump to navigation
Jump to search
imported>Medgirl131 |
imported>Medgirl131 |
||
| Line 21: | Line 21: | ||
* [[Azatadine]] | * [[Azatadine]] | ||
* [[Bamipine]] | * [[Bamipine]] | ||
| − | * [[Benzatropine|Benzatropine | + | * [[Benzatropine|Benzatropine (benztropine)]] |
* [[Bepotastine]] | * [[Bepotastine]] | ||
* [[Bromazine]] | * [[Bromazine]] | ||
| Line 50: | Line 50: | ||
* [[Embramine]] | * [[Embramine]] | ||
* [[Etodroxizine]] | * [[Etodroxizine]] | ||
| − | * [[Etybenzatropine|Etybenzatropine | + | * [[Etybenzatropine|Etybenzatropine (ethylbenztropine)]] |
* [[Etymemazine]] | * [[Etymemazine]] | ||
* [[Flunarizine]] | * [[Flunarizine]] | ||
| Line 60: | Line 60: | ||
* [[Isothipendyl]] | * [[Isothipendyl]] | ||
* [[Meclozine]] | * [[Meclozine]] | ||
| − | * [[Mepyramine|Mepyramine | + | * [[Mepyramine|Mepyramine (pyrilamine)]] |
* [[Mequitazine]] | * [[Mequitazine]] | ||
* [[Methafurylene]] | * [[Methafurylene]] | ||
| Line 167: | Line 167: | ||
* [[Lafutidine]] | * [[Lafutidine]] | ||
* [[Lamtidine]] | * [[Lamtidine]] | ||
| − | * [[Lavoltidine|Lavoltidine | + | * [[Lavoltidine|Lavoltidine (loxtidine)]] |
* [[Lupitidine]] | * [[Lupitidine]] | ||
* [[Metiamide]] | * [[Metiamide]] | ||
| Line 176: | Line 176: | ||
* [[Oxmetidine]] | * [[Oxmetidine]] | ||
* [[Pibutidine]] | * [[Pibutidine]] | ||
| − | * [[Quisultazine|Quisultazine | + | * [[Quisultazine|Quisultazine (quisultidine)]] |
* [[Ramixotidine]] | * [[Ramixotidine]] | ||
* [[Ranitidine]] | * [[Ranitidine]] | ||
| Line 198: | Line 198: | ||
* [[A-423,579]] | * [[A-423,579]] | ||
* [[ABT-239]] | * [[ABT-239]] | ||
| + | * [[ABT-652]] | ||
| + | * [[AZD5213]] | ||
* [[Betahistine]] | * [[Betahistine]] | ||
* [[Burimamide]] | * [[Burimamide]] | ||
| Line 206: | Line 208: | ||
* [[Impentamine]] | * [[Impentamine]] | ||
* [[Iodophenpropit]] | * [[Iodophenpropit]] | ||
| − | * [[JNJ-5207852 | + | * [[Irdabisant]] |
| + | * [[JNJ-5207852]] | ||
* [[MK-0249]] | * [[MK-0249]] | ||
| − | * [[NNC 38-1049 | + | * [[NNC 38-1049]] |
* [[PF-03654746]] | * [[PF-03654746]] | ||
* [[Pitolisant]] | * [[Pitolisant]] | ||
| − | * [[SCH-79687 | + | * [[SCH-79687]] |
* [[Thioperamide]] | * [[Thioperamide]] | ||
| − | * [[VUF-5681 | + | * [[VUF-5681]] |
| group4 = [[Histamine H4 receptor|H<sub>4</sub>]] | | group4 = [[Histamine H4 receptor|H<sub>4</sub>]] | ||
| Line 220: | Line 223: | ||
* [[alpha-Methylhistamine|α-Methylhistamine]] | * [[alpha-Methylhistamine|α-Methylhistamine]] | ||
* [[Histamine]] | * [[Histamine]] | ||
| − | * [[VUF-8430 | + | * [[VUF-8430]]<br/>'''Antagonists''': [[JNJ-7777120]] |
| + | * [[JNJ-38518168]] | ||
* [[Thioperamide]] | * [[Thioperamide]] | ||
| − | * [[VUF-6002 | + | * [[VUF-6002]] |
}} | }} | ||
Revision as of 02:50, 4 January 2015
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Histamine receptor modulators|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Histamine receptor modulators|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Histamine receptor modulators|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.